The role of calcium-independent phospholipase A2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heart

Journal of Lipid Research

Volumn 51, Issue 3, 2010, Pages 525-534

  Zachman, Derek K ^a   Chicco, Adam J ^b   McCune, Sylvia A ^a   Murphy, Robert C ^c   Moore, Russell L ^a   Sparagna, Genevieve C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Bromoenol lactone; Linoleic acid; Phosphatidylglycerol; Phospholipid remodeling

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CARDIOLIPIN; GLYCEROPHOSPHOLIPID; TETRALINOLEOYL CARDIOLIPIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT;

ANIMALS; CARDIOLIPINS; ENZYME INHIBITORS; FEMALE; HEART; HEART FAILURE; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; RATS; RATS, INBRED SHR; STRESS, PHYSIOLOGICAL; TIME FACTORS; TISSUE SURVIVAL;

EID: 77950619587     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M000646     Document Type: Article

References (68)

1. Mileykovskaya, E., M. Zhang, and W. Dowhan. 2005. Cardiolipin in energy transducing membranes. Biochemistry. 70: 154-158. (Pubitemid 40512322)
2. Hatch, G. M. 2004. Cell biology of cardiac mitochondrial phospho-lipids. Biochem. Cell Biol. 82: 99-112.
3. Van, Q., J. Liu, B. Lu, K. R. Feingold, Y. Shi, R. M. Lee, and G. M. Hatch. 2007. Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cells. Biochem. J. 401: 103-109.
4. Hovius, R., J. Thijssen, P. van der Linden, K. Nicolay, and B. de Kruijff. 1993. Phospholipid asymmetry of the outer membrane of rat liver mitochondria. Evidence for the presence of cardiolipin on the outside of the outer membrane. FEBS Lett. 330: 71-76.
5. Musatov, A. 2006. Contribution of peroxidized cardiolipin to inac-tivation of bovine heart cytochrome c oxidase. Free Radic. Biol. Med. 41: 238-246.
6. Chicco, A. J., and G. C. Sparagna. 2007. Role of cardiolipin altera-tions in mitochondrial dysfunction and disease. Am. J. Physiol. Cell Physiol. 292: C33-C44.
7. Zhang, M., E. Mileykovskaya, and W. Dowhan. 2002. Gluing the re-spiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J. Biol. Chem. 277: 43553-43556.
8. Paradies, G., G. Petrosillo, M. Pistolese, N. Di Venosa, D. Serena, and F. M. Ruggiero. 1999. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic. Biol. Med. 27: 42-50.
9. 2 digestion of cardiolipin bound to bovine cytochrome c oxidase alters both activity and quaternary structure. Biochemistry. 38: 14966-14972.
10. Haines, T. H., and N. A. Dencher. 2002. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett. 528: 35-39.
11. Brown, L. R., and K. Wuthrich. 1977. NMR and ESR studies of the interactions of cytochrome c with mixed cardiolipin-phosphatidyl-choline vesicles. Biochim. Biophys. Acta. 468: 389-410.
12. Petrosillo, G., F. M. Ruggiero, and G. Paradies. 2003. Role of reac-tive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J. 17: 2202-2208.
13. Ardail, D., F. Lerme, and P. Louisot. 1992. Phospholipid import into mitochondria: possible regulation mediated through lipid polymorphism. Biochem. Biophys. Res. Commun. 186: 1384-1390.
14. Eilers, M., T. Endo, and G. Schatz. 1989. Adriamycin, a drug inter-acting with acidic phospholipids, blocks import of precursor proteins by isolated yeast mitochondria. J. Biol. Chem. 264: 2945-2950.
15. Mannella, C. A. 2006. Structure and dynamics of the mitochondrial inner membrane cristae. Biochim. Biophys. Acta. 1763: 542-548.
16. Sparagna, G. C., A. J. Chicco, R. C. Murphy, M. R. Bristow, C. A. Johnson, M. L. Rees, M. L. Maxey, S. A. McCune, and R. L. Moore. 2007. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J. Lipid Res. 48: 1559-1570.
17. Schlame, M., R. I. Kelley, A. Feigenbaum, J. A. Towbin, P. M. Heerdt, T. Schieble, R. J. A. Wanders, S. DiMauro, and T. J. J. Blanck. 2006. Phospholipid abnormalities in children with Barth syndrome. J. Am. Coll. Cardiol. 42: 1994-1999.
18. Sparagna, G. C., and E. J. Lesnefsky. 2008. Cardiolipin remodeling in the heart. J. Cardiovasc. Pharmacol. In press.
19. Hauff, K. D., and G. M. Hatch. 2006. Cardiolipin metabolism and Barth syndrome. Prog. Lipid Res. 45: 91-101.
20. Schlame, M., and M. Ren. 2006. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 580: 5450-5455.
21. Barth, P. G., F. Valianpour, V. M. Bowen, J. Lam, M. Duran, F. M. Vaz, and R. J. Wanders. 2004. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am. J. Med. Genet. A. 126A: 349-354.
22. Vreken, P., F. Valianpour, L. G. Nijtmans, L. A. Grivell, B. Plecko, R. J. A. Wanders, and P. G. Barth. 2000. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279: 378-382.
23. Heerdt, P. M., M. Schlame, R. Jehle, A. Barbone, D. Burkhoff, and T. J. J. Blanck. 2002. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann. Thorac. Surg. 73: 1216-1221.
24. Nasa, Y., Y. Sakamoto, A. Sanbe, H. Sasaki, F. Yamaguchi, and S. Takeo. 1997. Changes in fatty acid compositions of myocardial lip-ids in rats with heart failure following myocardial infarction. Mol. Cell. Biochem. 176: 179-189. (Pubitemid 27491481)
25. Han, X., J. Yang, K. Yang, Z. Zhongdan, D. R. Abendschein, and R. W. Gross. 2007. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry. 46: 6417-6428.
26. Hatch, G. M. 1994. Cardiolipin biosynthesis in the isolated heart. Biochem. J. 297: 201-208.
27. Hatch, G. M., and G. McClarty. 1996. Regulation of cardiolipin biosynthesis in H9c2 cardiac myoblasts by cytidine 5 ′-triphosphate. J. Biol. Chem. 271: 25810-25816.
28. Hostetler, K. Y., H. Van Den Bosch, and L. L. M. Van Deenen. 1972. The mechanism of cardiolipin biosynthesis in liver mitochondria. Biochim. Biophys. Acta. 260: 507-513.
29. Schlame, M., and K. Y. Hostetler. 1997. Cardiolipin synthase from mammalian mitochondria. Biochim. Biophys. Acta. 1348: 207-213.
30. Hatch, G. M. 1998. Cardiolipin: biosynthesis, remodeling and trafficking in the heart and mammalian cells. Int. J. Mol. Med. 1: 33-41.
31. Hatch, G. M. 1996. Regulation of cardiolipin biosynthesis in the heart. Mol. Cell. Biochem. 159: 139-148.
32. Xu, Y., A. Malhotra, M. Ren, and M. Schlame. 2006. The enzymatic function of tafazzin. J. Biol. Chem. 281: 39217-39224.
33. Taylor, W. A., and G. M. Hatch. 2003. Purification and character-ization of monolysocardiolipin acyltransferase from pig liver mitochondria. J. Biol. Chem. 278: 12716-12721.
34. Cao, J., Y. Liu, J. Lockwood, P. Burn, and Y. Shi. 2004. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyl-transferase (ALCAT-1) in mouse. J. Biol. Chem. 279: 31727-31734.
35. 2 gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype. J. Biol. Chem. 282: 34611-34622.
36. 2 in the pathogenesis of Barth syndrome. Proc. Natl. Acad. Sci. USA. 106: 2337-2341.
37. cp: a genetic model of congestive heart failure. In Mechanisms of Heart Failure. P. K. Singal, I. M. C. Dixon, M. A. Kluwer, and N. S. Dhalla, editors. Kluwer Academic Publishers, Boston. 91-106.
38. Haas, G. J., S. A. McCune, D. M. Brown, and R. J. Cody. 1995. Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model. Am. Heart J. 130: 806-811.
39. Gomez, A. M., H. H. Valdiva, H. Cheng, M. R. Lederer, L. F. Santana, M. B. Cannell, S. A. McCune, R. A. Altschuld, and W. J. Lederer. 1997. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 276: 800-806.
40. Li, Y. M., M. Steffes, T. Donnelly, C. Liu, H. Fuh, J. Basgen, R. Bucala, and H. Vlassara. 1996. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor amino-guanidine. Proc. Natl. Acad. Sci. USA. 93: 3902-3907.
41. Sample, J., J. G. Cleland, and A. M. Seymour. 2006. Metabolic re-modeling in the aging heart. J. Mol. Cell. Cardiol. 40: 56-63.
42. Lipman, R. D., C. E. Chrisp, D. G. Hazzard, and R. T. Bronson. 1996. Pathologic characterization of Brown Norway, Brown Norway x Fischer 344, and Fischer 344 x Brown Norway rats with relation to age. J. Gerontol. A Biol. Sci. Med. Sci. 51: B54-B59.
43. Chicco, A. J., S. A. McCune, C. A. Emter, G. C. Sparagna, M. L. Rees, D. A. Bolden, K. D. Marshall, R. C. Murphy, and R. L. Moore. 2008. Low-intensity exercise training delays heart failure and improves survival in female spontaneously hypertensive heart failure rats. Hypertension. 51: 1096-1102.
44. Emter, C. A., S. A. McCune, G. C. Sparagna, M. J. Radin, and R. L. Moore. 2005. Low-intensity exercise training delays onset of decom-pensated heart failure in spontaneously hypertensive heart failure rats. Am. J. Physiol. Heart Circ. Physiol. 289: H2030-H2038.
45. Cheung, J. Y., I. G. Thompson, and J. V. Bonventre. 1982. Effects of extracellular calcium removal and anoxia on isolated rat myocytes. Am. J. Physiol. Cell Physiol. 243: C184-C190.
46. Sparagna, G. C., C. A. Johnson, S. A. McCune, R. L. Moore, and R. C. Murphy. 2005. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J. Lipid Res. 46: 1196-1204.
47. Heyen, J. R. R., E. R. Blasi, K. Nikula, R. Rocha, H. A. Daust, G. Frierdich, J. F. Van Vleet, P. De Ciechi, E. G. McMahon, and A. E. Rudolph. 2002. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am. J. Physiol. Heart Circ. Physiol. 283: H1775-H1784.
48. Hacker, T. A., S. H. McKiernan, P. S. Douglas, J. Wanagat, and J. M. Aiken. 2006. Age-related changes in cardiac structure and function in Fischer 344 X Brown Norway hybrid rats. Am. J. Physiol. Heart Circ. Physiol. 290: H304-H311.
49. Schlame, M., B. Rustow, D. Kunze, H. Rabe, and G. Reichmann. 1986. Phosphatidylglycerol of rat lung. Intracellular sites of formation de novo and acyl species pattern in mitochondria, microsomes and surfactant. Biochem. J. 240: 247-252.
50. Houtkooper, R. H., H. Akbari, H. van Lenthe, W. Kulik, R. J. A. Wanders, M. Frentzen, and F. M. Vaz. 2006. Identification and characterization of human cardiolipin synthase. FEBS Lett. 580: 3059-3064.
51. Ostrander, D. B., G. C. Sparagna, A. A. Amoscato, J. B. McMillin, and W. Dowhan. 2001. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apo-ptosis. J. Biol. Chem. 276: 38061-38067.
52. Schlame, M., and B. Rustow. 1990. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem. J. 272: 589-595.
53. Schlame, M., J. A. Towbin, P. M. Heerdt, R. Jehle, S. Dimauro, and T. J. J. Blanck. 2002. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neurol. 51: 634-637.
54. Malhotra, A., Y. Xu, M. Ren, and M. Schlame. 2009. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacyl-ation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species. Biochim. Biophys. Acta. 1791: 314-320.
55. Schlame, M. 2009. Formation of molecular species of mitochondria cardiolipin: 2. A mathematical model of pattern formation by phospholipid transacylation. Biochim. Biophys. Acta. 1791: 321-325.
56. Saini-Chohan, H. K., M. G. Holmes, A. J. Chicco, W. A. Taylor, R. L. Moore, S. A. McCune, D. L. Hickson-Bick, G. M. Hatch, and G. C. Sparagna. 2009. Cardiolipin biosynthesis and remodeling enzymes are altered during the development of heart failure. J. Lipid Res. 50: 1600-1608.
57. Lee, H-J., J. Mayette, S. I. Rapoport, and R. P. Bazinet. 2006. Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis. 5: 2.
58. 2) attenuates mitochondrial phospholipid loss and is cardioprotective. Biochem. J. 362: 23-32.
59. 2 localizes in and protects mitochondria during apoptotic induction by staurosporine. J. Biol. Chem. 281: 22275-22288.
60. Clarke, S. D. 2000. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br. J. Nutr. 83: S59-S66.
61. Forman, B. M., J. Chen, and R. M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferators-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA. 94: 4312-4317.
62. Sampath, H., and J. M. Ntambi. 2005. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 25: 317-340.
63. 2 enzymes present in P388D 1 macrophages. J. Biol. Chem. 271: 6758-6765.
64. 2. Mechanism-based discrimination between calcium-dependent and-independent phos-pholipases A 2. J. Biol. Chem. 266: 7227-7232.
65. 2. Annu. Rev. Pharmacol. Toxicol. 39: 178-189.
66. Balsinde, J., and E. A. Dennis. 1996. Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D 1 macrophages. J. Biol. Chem. 271: 31937-31941.
67. 2. J. Biol. Chem. 278: 44683-44690.
68. 2 s. J. Biol. Chem. 277: 32807-32814.